Determinants of STI transmission

Exposure of susceptibles to infected individuals can be influenced through counseling of patients to reduce early sexual debut and concurrent sexual partners, and to promote the performance of safer sexual activities, including:

·         Nonpenetrative sexual acts,

·         Consistent and correct use of condom, and

·         STI and HIV testing followed by commitment to monogamy.

Efficiency of transmission during exposure between susceptible and infectious partners can be influenced by a number of primary care physician interventions. Advising patients to use “safer sex” practices such as condom and avoidance of unprotected vaginal or anal intercourse can substantially reduce the transmission of some STI pathogens. The application of epidemiologic treatment to patients who have had a known exposure to a STI can reduce transmission presumably by treating patients either before symptoms develop or during the incubation period of the infection. Other forms of post- exposure prophylaxis have been also been used to prevent HIV infection following needle - stick, or sexual assault exposure. Finally, physicians can reduce the infectivity of some infected individuals by the use of suppressive antimicrobial therapy.

  • Chronic Lifestyle Changes
  • Immunodeficiency
  • STI Viral Pathoges
  • Incubation period of the infection
  • Post-exposure prophylaxis
  • Suppressive antimicrobial therapy
  • Efficiency Of Transmission
  • Haematological Diagnosis

Related Conference of Determinants of STI transmission

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

Determinants of STI transmission Conference Speakers

Recommended Sessions

Related Journals

Are you interested in